Intraperitoneal salvage chemotherapy in ovarian cancer: Who is left to treat?
- 30 April 1992
- journal article
- editorial
- Published by Elsevier in Gynecologic Oncology
- Vol. 45 (1) , 1-2
- https://doi.org/10.1016/0090-8258(92)90481-w
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Characteristics of patients with small-volume residual ovarian cancer unresponsive to cisplatin-based ip chemotherapy: Lessons learned from a gynecologic oncology group phase II trial of ip cisplatin and recombinant α-interferonGynecologic Oncology, 1992
- Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin.Journal of Clinical Oncology, 1991